Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ling Tong

Showing results (471-480 of 479) with videos related to

Pageof 48
Sort By:
You have reached the last page of results.This site can display upto 479 results.
Bioorganic & Medicinal Chemistry Letters|August 4, 2012
Synthesis and SAR of pyridothiazole substituted pyrimidine derived HCV replication inhibitorsVinay M Girijavallabhan, Carmen Alvarez, Frank Bennett, et al.
Bioorganic & Medicinal Chemistry Letters|April 5, 2012
5-Benzothiazole substituted pyrimidine derivatives as HCV replication (replicase) inhibitorsAshok Arasappan, Frank Bennett, Vinay Girijavallabhan, et al.
Science Translational Medicine|January 12, 2022
The PET tracer [<sup>11</sup>C]MK-6884 quantifies M4 muscarinic receptor in rhesus monkeys and patients with Alzheimer's diseaseWenping Li, Yuchuan Wang, Talakad G Lohith, et al.
Nature Microbiology|April 22, 2024
Cerastecins inhibit membrane lipooligosaccharide transport in drug-resistant Acinetobacter baumanniiHao Wang, Andrii Ishchenko, Jason Skudlarek, et al.
Journal of Medicinal Chemistry|May 27, 2026
Discovery Process of Enlicitide, a Highly Engineered Macrocyclic Peptide Therapeutic, through Issue-Driven Fragment-Based Synthetic Assembly and SARHubert Josien, Anilkumar G Nair, Fa-Xiang Ding, et al.
Journal of Medicinal Chemistry|August 22, 2024
Cerastecin Inhibition of the Lipooligosaccharide Transporter MsbA to Combat <i>Acinetobacter baumannii</i>: From Screening Impurity to <i>In Vivo</i> EfficacyJason W Skudlarek, Andrew J Cooke, Helen J Mitchell, et al.
Journal of Medicinal Chemistry|December 8, 2022
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1<i>H</i>-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's DiseaseDavid A Candito, Vladimir Simov, Anmol Gulati, et al.
Nature|October 24, 2017
Association analysis identifies 65 new breast cancer risk lociKyriaki Michailidou, Sara Lindström, Joe Dennis, et al.
Nature Genetics|October 24, 2017
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancerRoger L Milne, Karoline B Kuchenbaecker, Kyriaki Michailidou, et al.
Pageof 48

Showing results (471-480 of 479) with videos related to

Sort By:
Pageof 48
You have reached the last page of results.This site can display upto 479 results.
Bioorganic & Medicinal Chemistry Letters|August 4, 2012
Synthesis and SAR of pyridothiazole substituted pyrimidine derived HCV replication inhibitorsVinay M Girijavallabhan, Carmen Alvarez, Frank Bennett, et al.
Bioorganic & Medicinal Chemistry Letters|April 5, 2012
5-Benzothiazole substituted pyrimidine derivatives as HCV replication (replicase) inhibitorsAshok Arasappan, Frank Bennett, Vinay Girijavallabhan, et al.
Science Translational Medicine|January 12, 2022
The PET tracer [<sup>11</sup>C]MK-6884 quantifies M4 muscarinic receptor in rhesus monkeys and patients with Alzheimer's diseaseWenping Li, Yuchuan Wang, Talakad G Lohith, et al.
Nature Microbiology|April 22, 2024
Cerastecins inhibit membrane lipooligosaccharide transport in drug-resistant Acinetobacter baumanniiHao Wang, Andrii Ishchenko, Jason Skudlarek, et al.
Journal of Medicinal Chemistry|May 27, 2026
Discovery Process of Enlicitide, a Highly Engineered Macrocyclic Peptide Therapeutic, through Issue-Driven Fragment-Based Synthetic Assembly and SARHubert Josien, Anilkumar G Nair, Fa-Xiang Ding, et al.
Journal of Medicinal Chemistry|August 22, 2024
Cerastecin Inhibition of the Lipooligosaccharide Transporter MsbA to Combat <i>Acinetobacter baumannii</i>: From Screening Impurity to <i>In Vivo</i> EfficacyJason W Skudlarek, Andrew J Cooke, Helen J Mitchell, et al.
Journal of Medicinal Chemistry|December 8, 2022
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1<i>H</i>-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's DiseaseDavid A Candito, Vladimir Simov, Anmol Gulati, et al.
Nature|October 24, 2017
Association analysis identifies 65 new breast cancer risk lociKyriaki Michailidou, Sara Lindström, Joe Dennis, et al.
Nature Genetics|October 24, 2017
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancerRoger L Milne, Karoline B Kuchenbaecker, Kyriaki Michailidou, et al.
Pageof 48